sullivan ryan j (15 Ergebnisse)

Zustand: Good. Ryan Merkle (illustrator). Item in good condition. Textbooks may not include supplemental items i.e. CDs, access codes etc.

Zustand: Very Good. Ryan Merkle (illustrator). Item in very good condition! Textbooks may not include supplemental items i.e. CDs, access codes etc.

Paperback. Zustand: Very Good. No Jacket. Ryan Merkle (illustrator). May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Paperback. Zustand: Brand New. 180 pages. 5.50x0.41x8.50 inches. In Stock.

Hardcover. Zustand: Brand New. 180 pages. 5.50x0.60x8.50 inches. In Stock.

Hardcover. Zustand: Good. Zustand des Schutzumschlags: Very Good. xiii, 322 p., [16] p. of plates (1 fold-out) : ill. ; 25 cm. ; ISBN: 0060103361; 9780060103361 LCCN: 73-4061 ; OCLC: 677300 ; LC: E184.I6; Dewey: 917.3/06/9162; B ; beige cloth with gold lettering in photographic dustjacket ; Contents : The F.I.F.'s -- What happened? -- In the beginning -- Everything but the light bulb -- Murray Bay -- Mr. McDonnell's Gimmick -- The greatest nose count of them all -- The original butter-and-egg man -- The wedding of the century -- The wheeler-dealers -- Ma and Pa D -- The bubble breaks -- The decline of Mr. Fall -- The silver kings -- Mr. Ryan's fortune --- And for my eldest son, one set of pearl studs -- The troubles of one house -- Why don't the nice people like us? -- High Society -- The Duchess Brady -- Atomic Tom -- The Buckley's of Great Elm -- The upward climb -- Sons of the priory, daughters of the Sacred Heart -- Royalty -- What did happen -- Problems in the back office -- To the bitter end -- Aftermath -- Robert the roue ; spotting on froe-edge ; otherwise G/VG. Book.

96 pp.; 26.9 x 24 cm.; glue bound; black-and-white & color; edition size unknown; unsigned and unnumbered; offset-printed; Issue no. 67 of the periodical "art / text," edited by Susan Kandel. Contents include: "Lobby: Dinner at Frank's," by Liam Gillick; "Torpor: Deep Chaos," by Chris Kraus; "User: Wireless Cosmopolitans," by Peter Lunenfeld; "Report: 48th Venice Biennale," by Barry Schwabsky; "SITE: Santa Fe Third International Biennial," by Ellen Berkovitch; "TYPE: Professional Me," by Frances Stark; "APROPOS: Smithson, Shakespeare & Satan," by Robert Linsley; "Sally Elesby: Life is a Verb," by Sue Spaid; "Raafat Ishak: Personal Archive," by D.J. Huppatz; "Shaun Kirby: Slow Crawl of Necessity," by Stephen O'Connell; "The Red Eye," art by Jeremy Blake, text by Theresa Duncan; American Psychos: The End of Art Cinema in the '90s," by Laurence A. Rickels; "Thomas Demand: Paper Chases," by Nancy Princenthal; "Doug Aitkin: Immoral Video," by David Hunt; "The Family Firm: Andreas Gursky & German Photography," by Norman Bryson Reviews by Alex Coles, Jan Tumlir, David Hunt, Mai-Thu Perret, Fabrice Stroun, Jeffrey Kastner, Stuart Koop, Charles LaBelle, Ryan Whyte, Michelle Grabner, Barry Schwabsky, Terry R. Myers, Julie Joyce, Peter Frank, Roger Sullivan, Stephen O'Connell, Blair French, Regine Basha, Charles Green, Juliana Engberg, Ihor Holubizky, Lars Bang Larsen, and Gavin Wade. Cover: Thomas Demand. Very Good. Dust soiling of covers with original pricing sticker on bottom left corner of recto. Rubbing and dust soiling of verso. Light edgewear with bumping of top left corner of verso. Contents clean and unmarked.

Zustand: New. In.

Zustand: New. In.

Zustand: New.

Hardcover. Zustand: Brand New. 1st edition. 204 pages. 9.25x6.25x0.75 inches. In Stock.

Zustand: New. BRAF Targets in Melanoma Editor(s): Sullivan, Ryan J. Series: Cancer Drug Discovery and Development. Num Pages: 212 pages, 5 black & white illustrations, 21 colour illustrations, 5 black & white tables, biography. BIC Classification: MJCL; MJK. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 13. Weight in Grams: 485. . 2014. 2015th Edition. hardcover. . . . . Books ship from the US and Ireland.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, the identification of a molecular target, the selection of molecules which effectively inhibit this target. What is starkly different about the development of this class of compounds, however, is that the mechanism of action of these agents are not as straightforward as was once previously assumed and the mechanisms of resistance that tumor cells employ to evade complete destruction are unlike any that have been described before. These discoveries in addition to utilization of modern molecular biology techniques have led to a series of hypotheses regarding which other types of molecules could be used in combination with BRAF-inhibitors in hopes of revolutionizing the potential of therapeutics in melanoma.

Kartoniert / Broschiert. Zustand: New.

Taschenbuch. Zustand: Neu. Neuware - This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, the identification of a molecular target, the selection of molecules which effectively inhibit this target. What is starkly different about the development of this class of compounds, however, is that the mechanism of action of these agents are not as straightforward as was once previously assumed and the mechanisms of resistance that tumor cells employ to evade complete destruction are unlike any that have been described before. These discoveries in addition to utilization of modern molecular biology techniques have led to a series of hypotheses regarding which other types of molecules could be used in combination with BRAF-inhibitors in hopes of revolutionizing the potential of therapeutics in melanoma.